atenolol has been researched along with Torsade de Pointes in 2 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Champeroux, P | 1 |
| Le Guennec, JY | 1 |
| Jude, S | 1 |
| Laigot, C | 1 |
| Maurin, A | 1 |
| Sola, ML | 1 |
| Fowler, JS | 1 |
| Richard, S | 1 |
| Thireau, J | 1 |
| Perry, GY | 1 |
| Kosar, EM | 1 |
2 other studies available for atenolol and Torsade de Pointes
| Article | Year |
|---|---|
The high frequency relationship: implications for torsadogenic hERG blockers.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Atenolol; Dogs; Electrocardiography; Ether-A-Go-Go | 2016 |
Problems in managing patients with long QT syndrome and implantable cardioverter defibrillators: a report of two cases.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Defibrillators, Implantable; Electrocardiography; Fema | 1996 |